MARKET

NUWE

NUWE

Nuwellis Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.510
-0.160
-5.99%
After Hours: 2.520 +0.01 +0.40% 18:37 09/16 EDT
OPEN
2.620
PREV CLOSE
2.670
HIGH
2.670
LOW
2.450
VOLUME
461.91K
TURNOVER
--
52 WEEK HIGH
12.57
52 WEEK LOW
2.450
MARKET CAP
16.40M
P/E (TTM)
-0.4770
1D
5D
1M
3M
1Y
5Y
Why Nuwellis Shares Are Trading Lower Today
Nuwellis (NASDAQ:NUWE) shares are trading lower after the company announced it priced a 3,483,120 share common stock offering at $2.50 per share.
Benzinga · 1d ago
Mid-Afternoon Market Update: Dow Jumps 250 Points; GreenSky Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded up 0.72% to 34,827.73 while the NASDAQ rose 0.58% to 15,125.38. The S&P also rose, gaining 0.82% to 4,479.33.
Benzinga · 1d ago
YY, NNVC and REKR among mid-day movers
Gainers: GreenSky (NASDAQ:GSKY) +53%. IronNet (NYSE:IRNT) +27%. Sphere (NASDAQ:ANY) +22%. Allied Healthcare Products (NASDAQ:AHPI) +19%. Actinium Pharmaceuticals (NYSE:ATNM) +16%. Ampio Pharmaceuticals (NYSE:AMPE) +15%. Inozyme Pharma (NASDAQ:INZY) +15%. S...
Seekingalpha · 1d ago
38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for claims related to the company's platform technology.
Benzinga · 1d ago
Ampio Pharmaceuticals, 180 Life Sciences leads healthcare gainers; Nuwellis, Berkeley Lights among major losers
Gainers: Ampio Pharmaceuticals (NYSE:AMPE) +22%, 180 Life Sciences (NASDAQ:ATNF) +17%, Brainstorm Cell Therapeutics (NASDAQ:BCLI) +15%, Instil Bio (NASDAQ:TIL) +16%, G Medical Innovations (NASDAQ:GMVD) +15%. Losers: Nuwellis (NASDAQ:NUWE) -26%, Berkeley Li...
Seekingalpha · 1d ago
Mid-Morning Market Update: Markets Mixed; Industrial Production Rises 0.4% In August
Following the market opening Wednesday, the Dow traded up 0.13% to 34,621.78 while the NASDAQ fell 0.25% to 14,999.72. The S&P also rose, gaining 0.03% to 4,444.41.
Benzinga · 1d ago
Melco Resorts & Entertainment, Hut 8 Mining, Theravance Biopharma among premarket losers' pack
Nuwellis (NASDAQ:NUWE) -28% after proposes stock offering Theravance Biopharma (NASDAQ:TBPH) -20% after ampreloxetine misses primary endpoint in late-stage orthostatic; on headcount cut to focus on respiratory disease portfolio hypotension study DAVIDsTEA ...
Seekingalpha · 1d ago
BRIEF-Nuwellis Reports Pricing of $8.7 Mln Underwritten Public Offering of Common Stock
reuters.com · 1d ago
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NUWE. Analyze the recent business situations of Nuwellis Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NUWE stock price target is 13.42 with a high estimate of 22.25 and a low estimate of 6.00.
EPS
Institutional Holdings
Institutions: 25
Institutional Holdings: 879.99K
% Owned: 13.47%
Shares Outstanding: 6.53M
TypeInstitutionsShares
Increased
5
30.50K
New
3
99.49K
Decreased
2
6.60K
Sold Out
4
819.17K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.49%
Healthcare Equipment & Supplies
-0.15%
Key Executives
Chairman/Director
John Erb
President/Chief Executive Officer
Nestor Jaramillo
Chief Financial Officer
George Montague
Senior Vice President/Chief Compliance Officer/General Counsel/Secretary
Neil Ayotte
Chief Accounting Officer/Controller
Paul Wotta
Lead Director/Independent Director
Warren Watson
Independent Director
Steven Brandt
Independent Director
Maria Costanzo
Independent Director
Jon Salveson
Independent Director
Gregory Waller
No Data
About NUWE
Nuwellis, Inc., formerly CHF Solutions, Inc., is a medical device company. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow system for ultrafiltration therapy that gently removes fluid and restores balance to patients suffering from fluid overload. The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System consists of three components: the console, which allows caregivers control of ultrafiltration therapy; the peripheral catheter draws blood from and returns blood to the patient, and the blood circuit set that filters the patient’s blood and collects excess water and salt. Its solutions also include RenalSense Clarity RMS, which is a kidney monitoring system that continuously measures urine output and flow, automatically displaying real-time data to the medical staff.

Webull offers kinds of Nuwellis Inc stock information, including NASDAQ:NUWE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUWE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NUWE stock methods without spending real money on the virtual paper trading platform.